Hua Ren Pharmaceutical: Hua Ren Century Group's shareholding dropped to below 5%

Hua Ren Pharmaceutical Industry Announcement: The information disclosure obligor Hua Ren Century Group and its concerted action person Liang Fudong collectively reduced the company's shares by 76.8855 million shares through centralized bidding and block trading from December 19, 2019 to March 3, 2026, accounting for 6.50% of the total share capital of the company. After the change, the shareholding ratio decreased to 4.999996%. Hua Ren Century Group currently holds 57.1782 million shares of the company, accounting for 4.84% of the total share capital; Liang Fudong holds 1.9324 million shares, accounting for 0.16% of the total share capital. This equity change will not result in a change in the company's controlling shareholder, actual controller, or corresponding control rights, nor will it have any impact on the company's financial situation or continuing operations.